Abstract
Here, we describe the characterization of the [2Fe-2S] clusters of arsenite oxidases from Rhizobium sp. NT-26 and Ralstonia sp. 22. Both reduced Rieske proteins feature EPR signals similar to their homologs from Rieske-cyt b complexes, with g values at 2.027, 1.88, and 1.77. Redox titrations in a range of pH values showed that both [2Fe-2S] centers have constant Em values up to pH 8 at ∼+210 mV. Above this pH value, the Em values of both centers are pH-dependent, similar to what is observed for the Rieske-cyt b complexes. The redox properties of these two proteins, together with the low Em value (+160 mV) of the Alcaligenes faecalis arsenite oxidase Rieske (confirmed herein), are in line with the structural determinants observed in the primary sequences, which have previously been deduced from the study of Rieske-cyt b complexes. Since the published Em value of the Chloroflexus aurantiacus Rieske (+100 mV) is in conflict with this sequence analysis, we re-analyzed membrane samples of this organism and obtain a new value (+200 mV). Arsenite oxidase activity was affected by quinols and quinol analogs, which is similar to what is found with the Rieske-cyt b complexes. Together, these results show that the Rieske protein of arsenite oxidase shares numerous properties with its counterpart in the Rieske-cyt b complex. However, two cysteine residues, strictly conserved in the Rieske-cyt b-Rieske and considered to be crucial for its function, are not conserved in the arsenite oxidase counterpart. We discuss the role of these residues.
Keywords: Bioenergetics, Electron Transfer, Enzyme Structure, Evolution, Iron-Sulfur Protein, EPR, Rieske Protein, Arsenite Oxidase, Bc1 Complex, Redox Potentials
Introduction
Since the first report of bacterial arsenite (AsIII)2 oxidation by Green in 1918 (1), numerous AsIII-oxidizing bacteria have been isolated from various environments. Apart from the two cases of Ectothiorhodospiraceae, Alkalilimnicola ehrlichii str. MLHE-1 (2), and PHS-1 (3), the enzyme responsible for this redox conversion has been shown to be arsenite oxidase (Aro; but also found in the literature as Aox or Aso, Refs. 4, 5), encoded by the aroA and aroB genes. The three-dimensional structure of Aro has been solved (6). The structure of the large AroA (or AoxB or AsoA) subunit (90–100 kDa), bearing a molybdopterin cofactor together with a [3Fe-4S] cluster, establishes the enzyme as a member of the large dimethyl sulfoxide reductase superfamily of molybdenum-containing enzymes (6). Corrresponding structural similarities demonstrate that the small AroB (or AoxA or AsoB) subunit (14 kDa), harboring a [2Fe-2S] cluster, belongs to the superfamily of Rieske proteins. Aro thus illustrates the “Janus Head” principle that many bioenergetic enzymes are built from a very limited number of basic units, which we have termed a “redox enzyme construction kit” (7).
The first member of the family of Rieske proteins was identified and characterized in 1964 in Helmut Beinert's laboratory (8) as a component of mitochondrial complex III. It stood out from other known iron sulfur proteins by its extraordinarily high reduction potential (HP). Over the ensuing 40 years, Rieske proteins have been shown to form a very large superfamily encompassing subunits of the Rieske-cyt b complexes (i.e. complexes homologous to complex III) (see Refs. 9 and 10), domains or subunits of dioxygenases (for review, see Refs. 11 and 12) as well as sulredoxin from Sulfolobus tokodaii (13), in addition to the above cited AroB proteins. The Rieske centers are thus present in highly diverse prokaryotic systems. The Rieske-cyt b complex performs electron transfer from membrane-diffusing quinols to small soluble or membrane-attached redox proteins and thereby participates in the generation of a proton motive potential. By transferring electrons from AsIII to a soluble cytochrome in the periplasm, Aro has been demonstrated to sustain chemolithoautotrophy in an aerobic respiration process. Although its precise integration into bioenergetic chains still needs to be established, Aro has therefore been proposed to bypass the Rieske-cyt b complex in prokaryotic aerobic heterotrophic bioenergetic chains (14). The dioxygenases are soluble cytoplasmic enzyme systems involved in the catabolism of aromatic compounds. They consist of two or three components that transfer electrons from reduced nucleotides (NADH) via flavin and [2Fe-2S] redox centers to a terminal oxygenase. In these systems, [2Fe-2S] centers can be found in one or two components (15).
Phylogenetic analysis of Aro and the Rieske-cyt b complexes strongly suggests that both systems existed in the common ancestor of bacteria and archaea (16) and that the emergence of these two very divergent enzymes from fundamental ancestral “building units” represents a very early event in the evolution of life (7). The substantially different enzymatic reactions of the two systems subsequently must have involved adaptation of the building blocks to specific functional requirements. Among these adaptations are the properties of the Rieske cluster.
As established crystallographically, all Rieske proteins contain a [2Fe-2S] cluster in which one of the iron atoms is coordinated by two histidines (6, 17–20) rather than the two cysteines of “common” [2Fe-2S] ferredoxins. As documented for the Rieske-cyt b complexes and dioxygenases, these His ligands are responsible for i) an unusual EPR spectrum characterized by a low gav value of ∼1.91 as compared with ∼1.94 for most “classical” ferredoxins (21) and ii) a reduction potential at least 400 mV more positive than that of the classical ferredoxins (for review, see Refs. 11 and 22) a property that set the Rieske cluster apart at its discovery in 1964. Detailed structural determinants for these properties have been deduced from a comparison of the Rieske-cyt b complex and the dioxygenase groups, and several residues close to the cluster have been proposed to distinguish the two groups. The fact that the Rieske components of dioxygenases lack the disulfide bond near the cluster, whereas this bridge is universally present in the subunit of Rieske-cyt b complexes has led to the proposal that the dioxygenase cases be referred to as “Rieske-type” rather than “Rieske” centers. Such clusters have reduction potentials between −150 and −50 mV, whereas genuine Rieske proteins (i.e. those in Rieske-cyt b complexes) have reduction potentials in the range +100 to +380 mV (11). As we will show below, the case of the AroB protein demonstrates that the distinction between “true” Rieske and Rieske-type proteins is not so clear.
In comparison to the proteins from dioxygenases and Rieske-cyt b complexes, very little is known about the Rieske subunit in Aro. The spectrum recorded on the enzyme from Alcaligenes faecalis suggested that the EPR properties of the Aro-Rieske subunit were very similar to the protein in Rieske-cyt b complexes (23). The spectra of both Rieske clusters actually are so similar that the g = 1.90 signal recorded on membranes of Chloroflexus aurantiacus was first interpreted as arising from a Rieske-cyt b complex (24). The genome sequence, however, revealed that C. aurantiacus doesn't possess a Rieske-cyt b complex and that this signal therefore must be due to Aro (16). The high sequence similarity between Aro- and Rieske-cyt b Rieskes (16) thus correlates with the similar EPR properties of their [2Fe-2S] centers. The potentiometric results obtained on the Aro of A. faecalis (25) and C. aurantiacus (24) moreover suggest that the redox properties of the Aro-Rieske cluster resemble those of the center in Rieske-cyt b complexes. In fact, redox titrations on the [2Fe-2S] center of A. faecalis and C. aurantiacus enzymes yield values of Em = +130 mV (at pH 6) and Em = +100 mV (at pH 7), respectively.
To ascertain whether the structural determinants for properties of the center from Rieske-cyt b complexes also apply to the Aro-Rieske cluster, we have studied in the present work two additional enzymes from Rhizobium sp. NT-26 (NT-26; 26) and Ralstonia sp. 22 (S22; 62, see accompanying paper), which are members of the α- and β-proteobacteria, respectively. We have determined the EPR power saturation and redox properties of their [2Fe-2S] clusters and analyzed the results in light of primary sequences and molecular structures. We have also re-examined the properties of the C. aurantiacus Rieske center by repeating selected experiments at higher protein concentrations. Since Aro- and Rieske-cyt b Rieskes are closely related, we have tested the ability of Aro-Rieskes to react with quinones or analogs. Altogether, our results establish common redox properties of the Aro [2Fe-2S] group. Re-examination of the ever-increasing number of Rieske-cyt b-Rieskes sequences and redox properties provide new insights into the structural determinants of the properties of the Rieske-clusters.
EXPERIMENTAL PROCEDURES
Growth of Bacteria
NT-26, S22, and A. faecalis were grown aerobically and heterotrophically at 28 °C in the presence of 5 mm AsIII as described previously (23, 26, 27). C. aurantiacus was grown photosynthetically at 55 °C as already described (28) in the additional presence of 2 mm AsIII.
Preparation of the Aro Samples for EPR
Titrations were performed on enriched enzymes from NT-26 A. faecalis and S22. Cells of NT-26 and of S22 or A. faecalis were resuspended in 50 mm MES, pH 5.5, and in 50 mm Tricine, pH 8, respectively. Cells were broken by two passages through a French press cell and obtained samples were centrifuged for 10 min at 12,000 × g. The resulting supernatants were centrifuged again for 1.5 h at 250,000 × g. In the case of S22 and A. faecalis, the soluble fraction obtained after this second centrifugation step was applied to a DEAE-Sepharose column as described in the accompanying paper (62). The total Aro fraction thus obtained, dialyzed against 15 mm MES/15 mm Tricine/15 mm AMPSO, was used for titration. For NT-26, the soluble fraction retrieved from the second centrifugation step was precipitated as described previously (26) by ammonium sulfate at 40% saturation. The soluble fraction obtained after a centrifugation for 20 min at 20,000 × g was dialyzed overnight against 15 mm MES/15 mm Tricine/15 mm AMPSO. pH values were adjusted by adding NaOH.
The titration of the Rieske center from C. aurantiacus was performed on membrane samples. Cells were suspended in 50 mm MOPS at pH 7.0 and broken by passing twice through a French press cell. Unbroken cells were eliminated by centrifugation at 12,000 × g for 10 min, and the “membrane fraction” was retrieved as the pellet from a subsequent ultracentrifugation for 1.5 h at 250,000 × g.
Aro Activity Assays
For activity assays, the enzymes from S22 and NT-26 were purified as described elsewhere (26, 27). Aro activity was measured optically in 50 mm Tricine, pH 8, at 37 °C, using 100 μm sodium AsIII as electron donor and 30 μm cytochrome as electron acceptor. This protocol introduces several modifications to that published by Anderson et al. (23) and used in subsequent studies (e.g. by Santini and vanden Holden (26)). As detailed in the accompanying paper (62) cytochromes now replace 2,4-dichlorophenolindophenol in a pH 8 buffer instead of a pH 6 buffer, and the assays were conducted at 37 °C instead of 20 °C. Aquifex aeolicus cytochrome c555 and horse heart cytochrome c were used for S22 and NT-26 enzymes, respectively. 100 μm dibromothymoquinone, 100 μm 5-undecyl-6-hydroxy-4,7-dioxobenzothiazole (UHDBT), or 200 μm stigmatellin were added to the enzyme for inhibition studies.
EPR Experiments
Redox titrations were performed on membrane samples or purified samples at 15 °C as described by Dutton (29) in the presence of the following redox mediators at 100 μm: ferrocen, 1,4 p-benzoquinone, 2,5-dimethyl-p-benzoquinone, 2-hydroxy-1,2-naphthoquinone, and 1,4-naphthoquinone. Reductive titrations were carried out using sodium dithionite, and oxidative titrations were carried out using ferricyanide. EPR spectra were recorded on a Bruker ElexSys X-band spectrometer fitted with an Oxford Instruments liquid helium cryostat and temperature control system.
Amino Acid Sequence Analysis
Amino acid sequences were aligned with the help of the program CLUSTAL (30) using the Blossom matrix and refined based on the available structures as detailed in Ref. 10.
RESULTS
As outlined in the introduction, all Rieske clusters are characterized by reduction potentials well above those of classical [2Fe-2S] ferredoxins. However, among these clusters, three subgroups can be distinguished with respect to their Em values. The group including the dioxygenase, have reduction potentials <0 mV. The second group, made up of Rieske proteins found in Rieske-cyt b complexes from ubiquinone-, plastoquinone-, or caldariellaquinone-oxidizing organisms, were titrated at 330 ± 60 mV. The third group corresponds to Rieske proteins found in Rieske-cyt b complexes from menaquinone-oxidizing organisms, and the respective clusters were titrated at 160 ± 50 mV. The values published for the A. faecalis and C. aurantiacus Aro-Rieske centers suggest that they belong to the last of these groups. In this work, we have characterized two additional Aro-Rieske proteins, purified from NT-26 and S22, and can now draw reliable conclusions on how to classify this new ensemble of Rieske proteins.
Reduction Potentials of the Aro-Rieske from NT-26 and S22 at pH 8
Experiments were first carried out at a pH of 8 because of the higher stability and activity of the enzymes at this pH (see accompanying paper, Ref. 62). The EPR spectra recorded at 15 K on ascorbate-reduced purified Aro from NT-26 and S22 featured a derivative-shaped gy signal at g = 1.88, a gx trough at g = 1.77 and a gz peak (partially obscured by a wide radical signal) at g = 2.027 (Fig. 1A, spectra a and b). The differing amplitude ratios of the gx and gy features of spectra a and b suggested that the NT-26 and S22 [2Fe-2S] clusters may have differing relaxation properties. Power saturation curves measured on the gx and gy lines quantitatively confirmed this. In the case of the S22 cluster, the gx feature saturated more readily than the gy feature, a situation that is typical also for the cluster in Rieske-cyt b complexes (31). In the case of the NT-26 cluster, however, the situation was reversed (Fig. 1B).
FIGURE 1.
EPR properties of the Aro Rieske center from NT-26 and S22. All spectra were recorded on an isolated complex. Reduction of the Rieske center was achieved by ascorbate. A, spectra a (NT-26) and b (S22) were recorded under nonsaturating conditions. The instrument settings were as follows: microwave frequency, 9.4 GHz; modulation amplitude, 3 mT; temperature, 15 K; and microwave power, 6.3 mT. B, power saturation curves measured on the gx (circles) and gy (squares) values of the ascorbate-reduced Rieske center from NT-26 (closed symbols) and S22 (open symbols) at 15 K. EPR conditions were as in A.
EPR spectra were next recorded under nonsaturating conditions. The very particular EPR spectral parameters, specific to Rieske clusters, allows their characterization even in nonpurified samples. Because the final yield of enzyme purification was only in the range of 30% (26 and 62, accompanying paper), we performed EPR titrations on partially purified but substantially more concentrated enzyme samples (see “Experimental Procedures”) to obtain stronger signals. In both cases (NT-26 and S22), the observed signals (data not shown) were identical to those seen with purified enzymes. Because the AroB spectrum was readily observed in samples reduced by ascorbate, the only further center susceptible to contribute to the spectrum is the Rieske center of the Rieske-cyt b complexes in NT-26 and S22. However, the Rieske protein of the Rieske-cyt b complex is membrane-attached, anchored by its uncleaved twin arginine translocation signal sequence, and cannot be extracted from the membrane without detergent treatment (see Ref. 32). It therefore appeared unlikely that this protein might contribute to the spectrum in samples obtained without detergent extraction (see “Experimental Procedures”).
Redox titrations of the Aro-Rieske cluster from NT-26 and S22 at pH 8, evaluated from the size of the gy feature, are presented on supplemental Fig. S1. The determined Em values are similar with +225 ± 5 mV and +190 ± 5 mV for NT-26 and S22, respectively. These values are substantially higher than those reported for the Aro Rieske clusters from A. faecalis and C. aurantiacus.
These latter Em values were obtained at lower pH values. All Rieske-type clusters, however, have been demonstrated to show pH-dependent redox properties. The Rieske-cyt b subunit from neutrophilic organisms features Em values, which are pH-independent up to pH 8 and pH-dependent above this value with a slope of −60 mV/pH. Furthermore, in several cases, it has been shown that the pH dependence can attain a slope of −120 mV/pH at pH values >9. The Rieske-cyt b-Rieskes from acidophilic organisms and the dioxygenase ferredoxins show the same overall pH dependence only shifted by 2 pH units to lower and to higher pH values, respectively (22, 33, 34). Because the Em values reported at low pH values for A. faecalis and C. aurantiacus are lower than those determined for S22 and NT-26, the mentioned type of pH dependence cannot account for the difference between our values and those published. However, very peculiar pH dependences in Aro-Rieskes a priori cannot be excluded. We therefore next determined the redox potentials of the NT-26 and S22 Aro-Rieske clusters in the range between pH 6 and 9.5.
pH Dependence of Reduction Potentials of NT-26 and S22 Aro-Rieske Clusters
The dependence of Aro Rieske Em values versus pH is depicted in Fig. 2. The Em values obtained at pH 6, 7, and 8 suggest that the reduction potential is independent of pH up to pH 7.8 at a value of +225 ± 5 mV and +215 ± 5 mV for NT-26 and S22, respectively. The pH-dependence of the Aro-Rieske from S22 in the alkaline region can be interpreted as a decrease with a homogeneous slope of −60 mV/pH from 7.8 to 9.5. In the case of the NT-26 Aro-Rieske, the Em of the cluster versus pH dependence requires consideration of slopes of −60 mV/pH from 7.8 to 8.8 and of −120 mV/pH at very high pHs. These results agree with previous observation on neutrophilic Rieske-cyt b-Rieskes (reviewed in Ref. 11) featuring two pKa,ox values ∼ 7.6 and 9.2.
FIGURE 2.
The reduction potential of the Rieske center from NT-26 and S22 as a function of pH. The open and closed symbols represent data obtained with S22 and NT-26 enzyme, respectively. The data obtained on S22 Rieske are fitted by assuming two ionization equilibria with pKa values of 7.8 and 9.8 and an Em (low pH) of +215 mV, whereas the data obtained on NT-26 Rieske are fitted by assuming two ionization equilibria with pKa values of 7.8 and 8.8 and an Em (low pH) of +225 mV.
The pH dependence of Em thus does not provide an explanation for the difference between our results and the previously published values. While the Em values published for A. faecalis and C. aurantiacus are comparable with those for menaquinone-oxidizing Rieske-cyt b-Rieske centers, the values obtained for the NT-26 and S22 Aro-Rieskes are intermediate between those of menaquinone-oxidizing and of ubiquinone-, plastoquinone-, or caldariellaquinone-oxidizing Rieske-cyt b-Rieske proteins (22). Extensive studies of Rieske-cyt b complexes have established that selected residues involved in a complex hydrogen-bonding network near the cluster environment modulate its redox properties. Taking into account the close structural relationship between Aro- and Rieske-cyt b-Rieske centers, we therefore inspected the Aro-Rieske sequences to determine whether these hydrogen-bonding residues may account for the difference in Em between A. faecalis and C. aurantiacus on the one hand and NT-26 and S22 on the other hand.
Sequence Analysis of Aro-Rieske Proteins
Aro-Rieske sequences from NT-26, A. faecalis (AAR05655 (NT-26), AAQ19839), and C. aurantiacus (YP_001634828) are available in GenBank. Only a fragment of the S22 AroA subunit sequence was available (ABY19329) at the onset of this work. We made an effort to obtain the entire sequence of the S22 Aro-Rieske (GQ904715) and as discussed in the accompanying paper (62), the sequence obtained was astonishingly close to that of Achromobacter sp. SY8 (99% identity). A comparison was made of all four Aro-Rieske sequences to those of other Rieske proteins.
Rieske proteins (i.e. Aro-Rieske, Rieske-cyt b-Rieske) are composed of two distinct structural domains (10). The first, essentially represented by the N-terminal half of the primary sequence has only limited sequence similarity among Rieske proteins. On the other hand, the second domain, corresponding to the [2Fe-2S] cluster-binding domain, features strong similarities in proteins from all three domains of life allowing us to produce reliable multiple sequence alignments. An alignment corresponding to the cluster-binding domain is shown in Fig. 3. Sequences from S22 (GQ904715), NT-26 (AAR05655), A. faecalis (AAQ19839), C. aurantiacus fl.10 (YP_001634828), Aeropyrum pernix (NP_148694), and Pyrobaculum calidifontis (YP_001056257) Aro-Rieskes are compared with sequences from Rhodobacter sphaeroides (YP_354476), Thermus thermophilus (AAB91482), Sulfolobus acidocaldarius (CAA88318) Rieske-cyt b-Rieskes from Pseudomonas putida naphthalene dioxygenase (P0A110), and Burkholderia sp. LB400 biphenyl dioxygenase ferredoxin (BphF) (AAB63428).
FIGURE 3.
Sequence comparisons of cluster-binding domain of Rieske-type proteins. In A, sequences of Aro-Rieske from Ralstonia sp. 22 (Aro_S22, GQ904715), Rhizobium NT-26 (Aro_NT26, AAR05655.1), Alcaligenes faecalis (Aro_Alcfa, AAQ19839.1), Chloroflexus aurantiacus (Aro_Chlau, YP_001634828.1), Pyrobaculum calidifontis (Aro_Pyrca, YP_001056257.1), and Aeropyrum pernix K1 (AroB_Aerpe, NP_148694) are compared with sequences of Rieske-cyt b-Rieske from Rhodobacter sphaeroides (PetA_Rhosp, YP_354476.1), Thermus thermophilus (PetA_Theth, AAB91482.1) and Sulfolobus acidocaldarius (soxF_Sulac, CAA88318), of naphthalene dioxygenase-Rieske from Pseudomonas putida (NDO_Psepu, P0A110.1), and of BphF-Rieske from Burkholderia sp. LB400 (BphF_Bursp, AAB63428.1). The reduction potential-influencing Ser and Tyr residues (and eventual substitute) are marked by vertical black arrows. Fully conserved His and Cys residues binding the cluster are marked in boxes. Cys residues considered to form a disulfide bond in Rieske proteins are marked by gray arrows. In B, a schematic phylogenetic tree, reconstructed from detailed phylogenetic analysis (10), represents the distribution of the two important phylogenetic markers, i.e. the Ser and the disulfur bond (S-S) into the Rieske-cyt b and Aro clades in bacteria and archaea.
As exemplified by the R. sphaeroides or T. thermophilus sequences, in addition to the amino acids ligating the [2Fe-2S] center, two residues are strictly conserved in the cluster-binding domain of this protein, i.e. Cys134 and Cys151 (R. sphaeroides numbering; marked with gray arrows in Fig. 3), and these form a disulfide bond (17–20, 35). These residues have been implicated in the stability, the increase of Em value, and the catalytic activity of the protein (see Refs. 35–38). In contrast, these Cys are absent in dioxygenase ferredoxins, a fact which had been considered to be a crucial parameter setting these latter centers apart from those of the Rieske-cyt b complexes and that gave rise to the name “Rieske-type” clusters. Fig. 3 shows that the S22, but not the NT-26, protein possesses these Cys. An examination of all available Aro (39) sequences also revealed that none of the α-Proteobacteria (the phylum to which NT-26 belongs) and archaea, feature these Cys residues (data not shown here but presented in supplementary material of Lebrun et al.) (10). Aro-Rieskes from NT-26 and S22, however, have similar reduction potentials and stabilities (see preceding paragraph) similar to those of other AroBs (27, 40). This suggests that, at least in Aro, the disulfide bond in fact does not modulate the properties of the iron-sulfur cluster. Because these Cys residues are conserved in the Aros from both A. faecalis and C. aurantiacus, they furthermore cannot be the origin of the relatively low Em values seen in these proteins.
Another residue, which has been demonstrated to influence the reduction potential of the [2Fe-2S] cluster, is Tyr156 (R. sphaeroides numbering). This Tyr has been shown (38, 41, 42) to increase the Em value of the cluster by forming a hydrogen bridge with the sulfur atom of one of the cluster-ligating Cys (18–20, 35). It is noteworthy that, at present, none of the Aro-Rieskes examined here possesses this Tyr, but they all have phenylalanine instead. This Tyr is also replaced by Phe in all the “Rieske-type” proteins (see Fig. 3, residue marked in bold gray). Because this Phe is present in all of the Aro-Rieske sequences, including those of A. faecalis and C. aurantiacus, this cannot be the reason for the lower Em values of the two latter clusters compared with those of NT-26 and S22.
Finally, a serine (Ser-154 in the R. sphaeroides sequence) has been shown to be responsible for an increase of Em value of this cluster. Structural studies established that this Ser forms a hydrogen bridge with one of the bridging sulfur atoms. This Ser is observed in all sequences of HP Rieske-cyt b-Rieskes. In all Rieske-cyt b-Rieske centers that have a cluster reduction potential <+160 mV (low reduction potential) (11, 22), the hydrogen bond to this bridging sulfur atom is absent. As detailed above, the R. sphaeroides Rieske-cyt b-Rieske (with a cluster Em7 value of 300 mV, see Scheme 1) possesses this Ser residue, whereas T. thermophilus (having a Rieske-cluster Em7 value of 160 mV, see Scheme 1) has a glycine residue instead (for a comparative study, see Ref. 33). Naphthalene dioxygenase (having a “Rieske-type” cluster with an Em7 value of −150 mV) features a Trp at this position, and BphF (having a Rieske-type cluster with Em7 = −120 mV) a Gly (reviewed in Ref. 11). Among Aro-Rieske sequences, NT-26, S22, and C. aurantiacus also both have a Ser residue. The A. faecalis protein appears to be an exception with threonine in place of Ser. While the lower reduction potential published for the A. faecalis Aro-Rieske cluster (25) is consistent with the observed absence of Ser, this does not hold for the C. aurantiacus Aro-Rieske (24). Either the structural determinants for redox properties differ in Aro-Rieske clusters from those deduced for Rieske-cyt b clusters or the reduction potential determined for the Chloroflexus case is incorrect. We therefore re-examined the redox properties of the Aro-Rieske cluster from C. aurantiacus.
SCHEME 1.
Schematic representation of the reduction potential of the Rieske cofactor on a redox scale. Rectangles for menaquinone (MK) and high potential quinone (HPQ) using Rieske-cyt b denote the total redox range covered by complexes from the different characterized organisms. Values for Aro-Rieske are taken from this work.
Re-examination of the C. aurantiacus Aro-Rieske Cluster
Despite significant efforts, we were unable to purify enzyme in sufficient quantity for EPR characterization. As discussed above, the EPR spectrum of the Rieske center is unique and, in most cases, may be studied in membrane fragments. As reported previously (16), C. aurantiacus constitutes a conspicuous case, as the organism contains only one Rieske protein (i.e. the AroB subunit; YP_001634828), which is firmly associated to the membrane. The other Rieske-type protein (YP_001634332) identified by analysis of the C. aurantiacus whole genome is homologous to the ferredoxin from the naphthalene dioxygenase system (15), which is soluble. We therefore performed EPR titrations on membrane fragments, as described by Zannoni and Ingledew (24), using membrane fragments from bacteria grown in the presence of 2 mm AsIII. When membranes were progressively reduced from +350 mV to −100 mV, two signals were found to titrate in the 1.94–1.9 region. Fig. 4 depicts the evaluation of the EPR titration of the gy = 1.88 feature (open squares) but also the gy = 1.94 feature (closed squares) and the gx = 1.77 (closed triangles). Although noisy, the amplitude variation of the gy = 1.88 can be more satisfactorily fitted with two n = 1 Nernst components at Em = +50 mV and Em = +200 mV (straight line) than with only one at Em = +100 mV (dotted line). The amplitude variations of the gy = 1.94 and of the gy = 1.77 signals, by contrast, were nicely fitted using only one n = 1 Nernst component at Em = +50 mV and Em = +200 mV, respectively. These results suggest the presence of two independent paramagnetic species. The first one, with gy = 1.88 and gx = 1.77 at Em = +200 mV, arising from the Aro-Rieske cluster (see Fig. 1) and a second one having gy = 1.94, gx = 1.88 at Em value of +50 mV. It therefore appears highly probable that the g = 1.9 signal results from the overlap of two spectral species. This interpretation is reinforced by the observation of a shift of the g = 1.88 signal at lower reduction potentials (Fig. 4, inset). We therefore conclude that the Aro-Rieske from C. aurantiacus has a reduction potential of ∼+200 mV (Scheme 1).
FIGURE 4.
Redox titration at pH 7.0 on membranes from C. aurantiacus. Signal amplitudes at various ambient potentials were measured on the g = 1.88 (open squares), g = 1.77 (closed triangles), and g = 1.94 (closed squares) lines. The straight line through the open squares represent a theoretical curve with two n = 1 components with Em of +200 and +50 mV, whereas the dotted line through the open squares represent a theoretical curve with one n = 1 component with an Em of +100 mV. The g = 1.77 and g = 1.94 titrations are fitted with a n = 1 Nernst curve with an Em of +200 and +50 mV, respectively. Inset shows the signal shift observed during the titration on the g = 1.88 feature by comparing a spectrum recorded at +124 and −56 mV.
This value differs substantially from that published by Zannoni and Ingledew (24), which have interpreted the g = 1.9 signal as arising from a single paramagnetic center with Em = +100 mV. The growth conditions (2 mm AsIII) used for the present work favors aro gene expression (4, 14, 26, 43). The contribution of Aro-Rieske in our spectra is therefore expected to be significantly higher than in the membranes used in the previous work. Secondly, the titration of the g = 1.9 signal was obtained previously from spectra recorded at 40 K, rather than the 15 K used here. The higher measuring temperature has been shown to favor the spectral contribution of the cluster with Em = +50 mV yielding the g = 1.94 signal (24). Its contribution will be decreased at the 15 K used here. Bacterial growth and EPR conditions are therefore sufficient to explain why the biphasic character of the g = 1.9 titration was overlooked in the previous work.
Our EPR analysis indicates that the Aro-Rieske from C. aurantiacus has a reduction potential comparable to those for the NT-26 and S22 AroB proteins, i.e. in the vicinity of +200 mV and in line with the presence of the Ser residue in the cluster-binding motif. Thus, in Aro, just as in the Rieske-cyt b complexes, the presence of this Ser in the [2Fe-2S] cluster binding motif therefore appears to correlate well with a high (∼+210 mV) Em value (Scheme 1).
To compare the Em value of the A. faecalis cluster obtained with the same technique, we analyzed enriched soluble samples (see “Experimental Procedures”) from this strain using EPR redox titration. Such titrations, shown in supplemental Fig. S1, determined the reduction potential of the Rieske cluster from A. faecalis Aro to be +155 ± 15 mV. Thus, in Aros just as in the Rieske-cyt b complexes, the absence of the Ser residue in the [2Fe-2S] cluster-binding domain correlates with a low (well below +200 mV) Em value (Scheme 1).
Effect of Quinols and Analogs on Aro Activity
As presented in the introduction, the Rieske-cyt b complex is a quinol oxidase. The quinol binds to the Qo site, and interacts with the Rieske iron-sulfur protein. A strong hydrogen bond between the hydroxyl/phenoxy functions on the quinol/quinone and the Nϵ-proton on one of the histidine ligands had been proposed a long time ago (44) and was suggested to be crucial for quinol oxidation by Rieske-cyt b complexes (45) with a pK value for this Nϵ proton close to 8. Three-dimensional structures and EPR studies with stigmatellin, dibromothymoquinone, and UHDBT have confirmed this interaction (22, 35, 46–51). All these inhibitors are quinol analogs considered to be structural mimics of quinols or semiquinones (52, 53). The structurally close relationship between the AroB-subunit and its counterpart from Rieske-cyt b complexes as well as the conservation of a pK-value close to 8 for Aro-Rieskes studied in this work led us to test the effects of Rieske-cyt b complex inhibitors on the Aro.
We tested the effects of dibromothymoquinone, UHDBT and stigmatellin (with ethanol alone as control) on the AsIII oxidation activity of purified Aro from S22 and from NT-26. The strongest effect was obtained with stigmatellin, which yields up to 35% inhibition of cytochrome reduction (dotted line, Fig. 5). As illustrated by Fig. 5B, stigmatellin also induces EPR spectral changes on the S22 Aro-Rieske cluster, very similar to those observed with the center in Rieske-cyt b complexes (53), i.e. shifts of the gy and gx features. These spectral changes were not observed with the NT-26 enzyme. Dibromothymoquinone, and UHDBT induced little if any spectral change on the EPR spectrum of the Rieske subunit from both AroB proteins (data not shown). We furthermore titrated the NT-26 and S22 Aro-Rieske in the presence of 200 μm stigmatellin. The binding of this inhibitor has indeed been shown to result in a striking increase of the reduction potential of the Rieske-cyt b iron-sulfur cluster (53). We did not observe an equivalent shift of the reduction potential in any of the Aro [2Fe-2S] centers examined here (data not shown).
FIGURE 5.
Effect of stigmatellin on the S22 Aro-Rieske. A, kinetics recorded in absence (straight line) or in presence of 200 μm stigmatellin (dotted line) with isolated Aro from S22 in presence of 100 μm AsIII and 30 μm cytochrome at pH 8. B, EPR spectra recorded in absence (straight line) or in presence of 200 μm stigmatellin (dotted line) on isolated and ascorbate reduced Aro from S22. EPR conditions are as in Fig. 1.
We also tested quinol and quinone as inhibitors of Aro activity. Addition of quinones (data not shown) produces an inhibition of cytochrome reduction by Aro, comparable with that induced by stigmatellin.
DISCUSSION
The importance of selected residues in determining the spectral, redox, and catalytic properties of iron-sulfur clusters has been recognized for some time. Rieske proteins are well suited for such analyses. Sequence and structural comparisons of Rieske proteins from various systems have highlighted a significant degree of conservation in the C-terminal part of the protein, that is, the segment including the cluster-binding motif (10–12). The strong sequence diversity in this group (both from wild type and from mutated proteins) and the number of available crystal structures now allow for a reliable analysis of the individual effects of residues surrounding the cluster. This kind of analysis has already been carried out on the subgroup of the Rieske-cyt b proteins (38, 41, 42, 54). The Aro subgroup of Rieske proteins has not yet been examined in this way. Our present study has determined parameters required to extend the comparative approach to this group and therefore to include a new degree of sequence variation. In fact, two residues considered crucial for the properties of Rieske-cyt b subunits turn out not to be conserved in Aro-Rieske proteins.
Role of the Ser and Tyr Residues in the Vicinity of the Cluster
As shown by our EPR study on Aro-Rieske proteins, the reduction potentials of the [2Fe-2S] cluster of Aros from NT-26, S22, and C. aurantiacus, are in the region of +210 mV (Scheme 1). All three proteins have a conserved Ser in the cluster-binding motif (Fig. 3A). The A. faecalis Aro, however, contains a Thr in this position and also shows a substantially lower Em ∼+ 160 mV (Fig. 6) (this work and Ref. 25). In Aro, a hydrogen bridge between Ser and one of the cluster-bridging sulfur atoms is responsible for the higher Em values as is seen in the Rieske-cyt b complexes. This Thr also forms a hydrogen bond to the cluster-bridging sulfur, as shown in Fig. 6. Studies of the Rieske-cyt b (41, 42) have demonstrated that replacement of Ser by Thr in the Rieske-cyt b-Rieske produces only a small decrease (ΔEm = −26/28 mV) in Em as compared with substitutions fully eliminating the hydrogen bond, in line with the moderate decrease of Em in the A. faecalis [2Fe-2S] protein (Scheme 1).
FIGURE 6.
Structure of the Rieske-cluster binding pocket. The structure of crystallized Rieske-cyt b-Rieske from R. sphaeroides is compared with the structure of crystallized Aro-Rieske from A. faecalis and of modeled Aro-Rieske from NT-26. The residues implicated in the determination of cluster's redox properties and discussed in the text are indicated by their initials.
Aro-Rieskes from NT-26, S22, and C. aurantiacus show the sequence CPCHGSxF in the cluster-binding motif (Fig. 3), i.e. each contains a Phe replacing the canonical Tyr present in the R. sphaeroides wild type sequence. In the large majority of Rieske-cyt b-Rieskes (mutated or wild type (38, 41, 42, 55)) studied so far featuring this CPCHGSxF motif, an Em,7 value ∼+230 mV has been found, i.e. close to the Em,7 value cited above. In the case of mutagenesis, a 45–70 mV decrease compared with the wild type protein containing the CPCHGSxY sequence results from the absence of a hydrogen bond between Phe and a cluster-ligating Cys as shown by the crystal structure (35, 42). The structure of Aro demonstrates that the Phe residue in this enzyme is in exactly the same place as the Tyr residue in the Rieske-cyt b complex (Fig. 6).
Ser and Tyr residues appear therefore to play equivalent roles in Aro- and Rieske-cyt b- Rieskes but specific cases preclude a generalization of the “Ser and Tyr induce high Em” rule. The PetA protein from Aquifex aeolicus as well as sulredoxin from Sulfolobus tokodaii feature a Gly and an Ala, respectively, in place of the Ser residue, yet their Em values have been determined at ∼+200 mV (56, 57). On the other hand, PetA from Allochromatium vinosum bears the CPCHGSxF sequence (see supplementary material from Ref. 10) yet titrates at Em = +285 mV (see Ref. 11). Presently, we cannot determine whether these discrepancies are due to experimental problems (cf. the C. aurantiacus case) or whether they reflect the action of presently unidentified residues compensating the Ser and Tyr effects.
If the potential-increasing effect of the Ser residue was indeed a universal property of Rieske proteins, its presence in all basal branches of archaea and bacteria (Fig. 3B) presents a bioenergetic conundrum. We have pointed out previously (58, 59) that the ancestral Rieske-cyt b enzyme is likely to have operated in a menaquinone-based bioenergetic electron transfer chain, using a Rieske center with a correspondingly low reduction potential. The universality of the Ser-induces-high-Em rule would therefore suggest a different adaptation of the bioenergetic chain to the reduction potential of the quinone pool in all basal branches of archaea and bacteria. Unfortunately, only very limited electrochemical data are available presently for these phyla, and it remains for future studies to address this issue.
Role of the Disulfide Bond in Rieske Proteins
The disulfide bond has long been thought to be essential for cluster stability in Rieske proteins. This conclusion is based on the loss of the cluster in mitochondria upon treatment with 2,3-dimercaptopropanol (60) and on mutation of the disulfide Cys in the R. capsulatus Rieske-cyt b complex (36). The structures of naphthalene dioxygenase and BphF (17, 20), however, revealed that the disulfide bond is not indispensable (see Fig. 3). Subsequent mutagenesis studies with mitochondrial Rieske proteins support a more moderate role for this disulfide bond with effects only on redox properties, catalytic activity, and the EPR spectrum (37, 38). Our results suggest an even more modest role of this disulfide bond at least in Aro. Figs. 1 and 2 demonstrate that neither the EPR spectral rhombicity nor the Em values are significantly modified in Aro-Rieskes devoid of this disulfide bond (e.g. the NT-26 protein). We note that an error in the NT-26 AroB sequence is excluded since all α-proteobacterial and archaeal AroB sequences lack the disulfide bond. None of the residues that replace the two Cys, i.e. Phe/Gly, in these natural cases have, however, been tested in mutagenesis studies (37, 38).
Our results do suggest that the presence of a disulfide bond correlates with quinol-oxidizing activity and EPR saturation properties. Even if the effect of Rieske-cyt b inhibitors on Aro is greatly lower compared with Rieske-cyt b itself (i.e. 100%; see for example (37)), the fact that stigmatellin and quinols inhibit 35% of the Aro activity and perturb the EPR spectrum indicate that Aro binds quinols. Whether this interaction has a physiological role is beyond the scope of this study. The fact that the EPR signal of the NT-26 enzyme is not perturbed upon addition of stigmatellin possibly relates to the absence of the disulfide bond. Loss of reactivity toward inhibitors of Rieske-cyt b complexes and decrease of quinol-oxidizing activity have indeed previously been correlated with the absence of this bond (37, 38). Quinone and inhibitor binding by Aro thus challenges the Rieske-cyt b dogma that quinone binding is governed by the entire Qo site (Rieske and cyt b) and argues for an intrinsic affinity of the Rieske protein for quinones.
The Cys of the disulfide bond, together with selected residues surrounding the His ligands of the Rieske center (among them Thr130 and Leu132 in the R. sphaeroides numbering), have also been implicated in pK variations observed in Em versus pH dependences (11, 22, 38, 61). The hydrophobicity of the Leu and Thr residues have been proposed to rationalize i) why the coupling between cluster redox state and the His protonation state is less efficiently screened out in Rieske-cyt b complexes as compared with BphF and ii) why the cluster in Rieske-cyt b complexes has higher Em values than BphF. In the S22 Aro-Rieske, both the disulfide bond and the Thr residue are conserved, whereas Leu is replaced by Met. The similarity of the redox properties of this center to those of the Rieske-cyt b proteins thus appears logical. The simultaneous substitution of Leu and Thr in the NT-26 sequence with Lys and Pro introduces more significant changes in the chemical environment of the His. Although these changes entail only minor modifications of reduction potential, they appear to correlate with shift in pK value. These substitutions in NT-26 are concomitant with the absence of the disulfide bond, and it is presently impossible to attribute an individual role to any of these residues in shifting pK values. The observed pK shifts nevertheless fall dramatically short of reproducing the dependence observed in BphF, which is characterized by a >2 pH units more alkaline pK value. We therefore conclude that either the model put forward to explain the difference between the Rieske-cyt b complex and BphF does not apply to the Aro enzyme or, more likely, that other yet unidentified factors are involved.
Our results thus suggest that the disulfide bond, in Aro-Rieske, has little or no effect on the redox properties of its iron-sulfur cluster but confirm that its presence correlates with the pK values associated with the Em versus pH dependence, with quinol-oxidizing activity and with EPR saturation properties. Absence of the disulfide bond may furthermore correlate with strong selectivity toward specific cytochromes (62, accompanying paper). The determining factors of the selectivity of Aro for its cytochrome electron acceptors are not yet understood. We can, however, ascertain that the presence/absence of the disulfide bond in Aro-Rieske does so far correlate with cytochrome selectivity (40). Work aimed at further elucidating the structural basis for this selectivity is underway.
CONCLUSIONS
In the past, comparisons of the properties of Rieske proteins from diverse groups of Rieske-cyt b complexes and, in particular, their HP representatives on the one hand and the bacterial dioxygenases on the other have identified several residues potentially affecting the physicochemical properties of the iron-sulfur cluster. Six specific residues have been proposed to influence stability, spectroscopic parameters, reduction potential, and pH dependence, i.e. the two residues close to the cluster-ligating His, the Ser and Tyr residues forming hydrogen bonds with the cluster, and the two Cys residues forming the disulfide bond.
As we have detailed above, although our study indicates that presently unidentified residues may induce effects exclusively attributed to the Ser and Tyr positions, the role of the Ser and Tyr residues in the AroB subfamily appears to be similar to what has been observed on the remaining ensemble of Rieske proteins. Furthermore, the properties we have observed for the subgroup of α-proteobacterial AroB proteins, typified by the NT-26 enzyme, strongly argue against the dramatic influence on cluster properties ascribed previously to the disulfide bond.
Combined molecular phylogenies of Rieske-cyt b complexes and Aro indicate that i) both enzyme families already existed in the last universal common ancestor of bacteria and archaea and ii) their Rieske subunits are related (10, 16) and share a common ancestor. The results obtained with the superfamily of Rieske proteins allows us, by analyzing the distribution of evolutionary markers on the reconstructed phylogenetic tree, to deduce some of the basic properties of this ancestral Rieske protein (Fig. 3B). The fact that all Rieske subunits in Rieske-cyt b complexes as well as the majority of AroBs contain the disulfide bond, qualify this as likely being in the ancestor of Rieske-cyt b complexes and Aros. In the same vein, the Ser residue forming a hydrogen bond with one of the cluster sulfur atoms also is likely to already have been present in the common ancestor. Finally, our results suggest that Aros, in addition to Rieske-cyt b complexes, are able to react with quinols. This suggests that the common ancestor of Rieske proteins was likely already able to bind quinones. The absence of these traits in the bacterial dioxygenases reflects that they represent a more recently evolved subgroup, a conclusion in line with their limited occurrence in a few proteobacterial species.
Supplementary Material

The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. S1.
- AsIII
- arsenite
- AMPSO
- 3-((1,1-dimethyl-2-hydroxyethyl)amino)-2-hydroxypropanesulfonic acid
- BphF
- biphenyl dioxygenase ferredoxin
- HP
- high reduction potential
- MES
- 2-(N-morpholino)ethanesulfonic acid
- MOPS
- 3-(morpholino)propanesulfonic acid
- UHDBT
- 5-undecyl-6-hydroxy-4,7-dioxobenzothiazole.
REFERENCES
- 1.Green H. H. (1918) S. Afr. J. Sci. 14, 465–467 [Google Scholar]
- 2.Hoeft S. E., Blum J. S., Stolz J. F., Tabita F. R., Witte B., King G. M., Santini J. M., Oremland R. S. (2007) Int. J. Syst. Evol. Microbiol. 57, 504–512 [DOI] [PubMed] [Google Scholar]
- 3.Kulp T. R., Hoeft S. E., Asao M., Madigan M. T., Hollibaugh J. T., Fisher J. C., Stolz J. F., Culbertson C. W., Miller L. G., Oremland R. S. (2008) Science 321, 967–970 [DOI] [PubMed] [Google Scholar]
- 4.Muller D., Lièvremont D., Simeonova D. D., Hubert J. C., Lett M. C. (2003) J. Bacteriol. 185, 135–141 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Silver S., Phung L. T. (2005) Appl. Environ. Microbiol. 71, 599–608 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ellis P. J., Conrads T., Hille R., Kuhn P. (2001) Structure 9, 125–132 [DOI] [PubMed] [Google Scholar]
- 7.Baymann F., Lebrun E., Brugna M., Schoepp-Cothenet B., Giudici-Orticoni M. T., Nitschke W. (2003) Philos. Trans. R. Soc. Lond. B Biol. Sci. 358, 267–274 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Rieske J. S., Hansen R. E., Zaugg W. S. (1964) J. Biol. Chem. 239, 3017–3022 [PubMed] [Google Scholar]
- 9.Schütz M., Brugna M., Lebrun E., Baymann F., Huber R., Stetter K. O., Hauska G., Toci R., Lemesle-Meunier D., Tron P., Schmidt C., Nitschke W. (2000) J. Mol. Biol. 300, 663–675 [DOI] [PubMed] [Google Scholar]
- 10.Lebrun E., Santini J. M., Brugna M., Ducluzeau A. L., Ouchane S., Schoepp-Cothenet B., Baymann F., Nitschke W. (2006) Mol. Biol. Evol. 23, 1180–1191 [DOI] [PubMed] [Google Scholar]
- 11.Link T. A. (1999) Adv. Inorg. Chem. 47, 83–157 [Google Scholar]
- 12.Schmidt C. L., Shaw L. (2001) J. Bioenerg. Biomemb. 33, 9–26 [DOI] [PubMed] [Google Scholar]
- 13.Iwasaki T., Isogai T., Lizuka T., Oshima T. (1995) J. Bacteriol. 177, 2576–2582 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.vanden Hoven R. N., Santini J. M. (2004) Biochim. Biophys. Acta 1656, 148–155 [DOI] [PubMed] [Google Scholar]
- 15.Mason J. R., Cammack R. (1992) Annu. Rev. Microbiol. 46, 277–305 [DOI] [PubMed] [Google Scholar]
- 16.Lebrun E., Brugna M., Baymann F., Muller D., Lièvremont D., Lett M. C., Nitschke W. (2003) Mol. Biol. Evol. 20, 686–693 [DOI] [PubMed] [Google Scholar]
- 17.Kauppi B., Lee K., Carredano E., Parales R. E., Gibson D. T., Eklund H., Ramaswamy S. (1998) Structure 6, 571–586 [DOI] [PubMed] [Google Scholar]
- 18.Iwata S., Saynovits M., Link T. A., Michel H. (1996) Structure 4, 567–579 [DOI] [PubMed] [Google Scholar]
- 19.Carrell C. J., Zhang H., Cramer W. A., Smith J. L. (1997) Structure 5, 1613–1625 [DOI] [PubMed] [Google Scholar]
- 20.Colbert C. L., Couture M. M., Eltis L. D., Bolin J. T. (2000) Structure 8, 1267–1278 [DOI] [PubMed] [Google Scholar]
- 21.Bertrand P., Gayda J. P., Fee J. A., Kuila D., Cammack R. (1987) Biochim. Biophys. Acta 916, 24–28 [DOI] [PubMed] [Google Scholar]
- 22.Schoepp B., Brugna M., Lebrun E., Nitschke W. (1999) Adv. Inorg. Chem. 47, 335–360 [Google Scholar]
- 23.Anderson G. L., Williams J., Hille R. (1992) J. Biol. Chem. 267, 23674–23682 [PubMed] [Google Scholar]
- 24.Zannoni D., Ingledew W. J. (1985) FEBS Lett. 193, 93–98 [Google Scholar]
- 25.Hoke K. R., Cobb N., Armstrong F. A., Hille R. (2004) Biochemistry 43, 1667–1674 [DOI] [PubMed] [Google Scholar]
- 26.Santini J. M., vanden Hoven R. N. (2004) J. Bacteriol. 186, 1614–1619 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Lieutaud A. (2007) Étude pour la mise au point d'un biocapteur ampérométrigue à arsénite utilisent l'arsénite oxydase. PhD thesis, Université de Provence, Marseilles, France [Google Scholar]
- 28.Pierson B. K., Castenholz R. W. (1974) Arch. Microbiol. 100, 5–24 [DOI] [PubMed] [Google Scholar]
- 29.Dutton P. L. (1971) Biochim. Biophys. Acta 226, 63–80 [DOI] [PubMed] [Google Scholar]
- 30.Higgins D. G., Sharp P. M. (1989) Comput. Appl. Biosci. 5, 151–153 [DOI] [PubMed] [Google Scholar]
- 31.Riedel A., Rutherford A. W., Hauska G., Müller A., Nitschke W. (1991) J. Biol. Chem. 266, 17838–17844 [PubMed] [Google Scholar]
- 32.Kallas T. (1994) in The Molecular Biology of Cyanobacteria (Bryant D. A. ed) pp. 259–317, Kluwer Academic Publishers, Dordrecht, The Netherlands [Google Scholar]
- 33.Zu Y., Manon M. J., Kolling D. R., Crofts A. R., Eltis L. D., Fee J. A., Hirst J. (2003) Biochemistry 42, 12400–12408 [DOI] [PubMed] [Google Scholar]
- 34.Brugna M., Nitschke W., Asso M., Guigliarelli B., Lemesle-Meunier D., Schmidt C. (1999) J. Biol. Chem. 274, 16766–16772 [DOI] [PubMed] [Google Scholar]
- 35.Zhang Z., Huang L., Shulmeister V. M., Chi Y. I., Kim K. K., Hung L. W., Crofts A. R., Berry E. A., Kim S. H. (1998) Nature 392, 677–684 [DOI] [PubMed] [Google Scholar]
- 36.Davidson E., Ohnishi T., Atta-Asafo-Adjei E., Daldal F. (1992) Biochemistry 31, 3342–3351 [DOI] [PubMed] [Google Scholar]
- 37.Merbitz-Zahradnik T., Zwicker K., Nett J. H., Link T. A., Trumpower B. L. (2003) Biochemistry 42, 13637–13645 [DOI] [PubMed] [Google Scholar]
- 38.Leggate E. J., Hirst J. (2005) Biochemistry 44, 7048–7058 [DOI] [PubMed] [Google Scholar]
- 39.Duval S., Ducluzeau A. L., Nitschke W., Schoepp-Cothenet B. (2008) BMC Evol. Biol. 8, 206–219 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Duval S. (2008) Ph.D. thesis, Université de Provence, Marseilles, France [Google Scholar]
- 41.Denke E., Merbitz-Zahradnik T., Hatzfeld O. M., Snyder C. H., Link T. A., Trumpower B. L. (1998) J. Biol. Chem. 273, 9085–9093 [DOI] [PubMed] [Google Scholar]
- 42.Kolling D. J., Brunzelle J. S., Lhee S., Crofts A. R., Nair S. K. (2007) Structure 15, 29–38 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Kashyap D. R., Botero L. M., Franck W. L., Hassett D. J., McDermott T. R. (2006) J. Bacteriol. 188, 1081–1088 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Ding H., Moser C. C., Robertson D. E., Tokito M. K., Daldal F., Dutton P. L. (1995) Biochemistry 34, 15979–15996 [DOI] [PubMed] [Google Scholar]
- 45.Ugulava N. B., Crofts A. R. (1998) FEBS Lett. 440, 409–413 [DOI] [PubMed] [Google Scholar]
- 46.Iwata S., Lee J. W., Okada K., Lee J. K., Iwata M., Rasmussen B., Link T. A., Ramaswamy S., Jap B. K. (1998) Science 281, 64–71 [DOI] [PubMed] [Google Scholar]
- 47.Schoepp B., Brugna M., Riedel A., Nitschke W., Kramer D. M. (1999) FEBS Lett. 450, 245–250 [DOI] [PubMed] [Google Scholar]
- 48.Hunte C., Koepke J., Lange C., Rossmanith T., Michel H. (2000) Structure 8, 669–684 [DOI] [PubMed] [Google Scholar]
- 49.Palsdottir H., Lojero C. G., Trumpower B. L., Hunte C. (2003) J. Biol. Chem. 278, 31303–31311 [DOI] [PubMed] [Google Scholar]
- 50.Stroebel D., Choquet Y., Popot J. L., Picot D. (2003) Nature 426, 413–418 [DOI] [PubMed] [Google Scholar]
- 51.Kurisu G., Zhang H., Smith J. L., Cramer W. A. (2003) Science 302, 1009–1014 [DOI] [PubMed] [Google Scholar]
- 52.Thierbach G., Kunze B., Reichenbach H., Höfle G. (1984) Biochim. Biophys. Acta 765, 227–235 [Google Scholar]
- 53.von Jagow G., Ohnishi T. (1985) FEBS Lett. 185, 311–315 [DOI] [PubMed] [Google Scholar]
- 54.Schröter T., Hatzfeld O. M., Gemeinhardt S., Korn M., Friedrich T., Ludwig B., Link T. A. (1998) Eur. J. Biochem. 255, 100–106 [DOI] [PubMed] [Google Scholar]
- 55.Henninger T., Anemüller S., Fitz-Gibbon S., Miller J. H., Schäfer G., Schmidt C. L. (1999) J. Bioenerg. Biomembr. 31, 119–128 [DOI] [PubMed] [Google Scholar]
- 56.Schütz M., Schoepp-Cothenet B., Lojou E., Woodstra M., Lexa D., Tron P., Dolla A., Durand M. C., Stetter K. O., Baymann F. (2003) Biochemistry 42, 10800–10808 [DOI] [PubMed] [Google Scholar]
- 57.Iwasaki T., Imai T., Urushiyama A., Oshima T. (1996) J. Biol. Chem. 271, 27659–27663 [DOI] [PubMed] [Google Scholar]
- 58.Nitschke W., Kramer D. M., Riedel A., Liebl U. (1995) Photosynthesis: From Light to Biosphere (Mathis P. ed) Vol. I, pp. 945–950, Kluwer Academic Publishers, Dordrecht, the Netherlands [Google Scholar]
- 59.Schoepp-Cothenet B., Lieutaud C., Baymann F., Verméglio A., Friedrich T., Kramer D. M., Nitschke W. (2009) Proc. Natl. Acad. Sci. U.S.A. 106, 8549–8554 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Slater E. C., de Vries S. (1980) Nature 288, 717–718 [DOI] [PubMed] [Google Scholar]
- 61.Liebl U., Sled V., Brasseur G., Ohnishi T., Daldal F. (1997) Biochemistry 36, 11675–11684 [DOI] [PubMed] [Google Scholar]
- 62.Lieutaud A., van Lis R., Duval S., Capowiez L., Muller D., Lebrun R., Lignon S., Fardeau M. L., Lett M. C., Nitschke W., Schoepp-Cothenet B. (2010) J. Biol. Chem. 285, 20433–20441 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.







